Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging.
about
Simultaneous fMRI-PET of the opioidergic pain system in human brainDynamic positron emission tomography image restoration via a kinetics-induced bilateral filterStriatal Dopamine D2/D3 Receptor Availability Is Associated with Executive Function in Healthy Controls but Not Methamphetamine UsersEarly AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study.Robust fitting of [11C]-WAY-100635 PET data.Imaging serotonergic transmission with [11C]DASB-PET in depressed and non-depressed patients infected with HIV.Voxel-based estimation of kinetic model parameters of the L-[1-(11)C]leucine PET method for determination of regional rates of cerebral protein synthesis: validation and comparison with region-of-interest-based methodsQuantitative analysis of [18F]FDDNP PET using subcortical white matter as reference regionStriatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivityTest-retest reproducibility of quantitative binding measures of [11C]Ro15-4513, a PET ligand for GABAA receptors containing alpha5 subunits.Dopamine D₃ receptor alterations in cocaine-dependent humans imaged with [¹¹C](+)PHNO.Serotonin 2A receptor agonist binding in the human brain with [¹¹C]Cimbi-36.Sex differences in striatal dopamine D2/D3 receptor availability in smokers and non-smokersA linear model for estimation of neurotransmitter response profiles from dynamic PET data.A spectral analysis approach for determination of regional rates of cerebral protein synthesis with the L-[1-(11)C]leucine PET method.Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.Translational possibility of [(18) F]Mefway to image serotonin 1A receptors in humans: Comparison with [(18) F]FCWAY in rodents.Measurement error analysis for the determination of dopamine D(2) receptor occupancy using the agonist radioligand [(11)C]MNPA.Dissociative changes in the Bmax and KD of dopamine D2/D3 receptors with aging observed in functional subdivisions of the striatum: a revisit with an improved data analysis methodImproved kinetic analysis of dynamic PET data with optimized HYPR-LRParametric Imaging and Test-Retest Variability of ¹¹C-(+)-PHNO Binding to D₂/D₃ Dopamine Receptors in Humans on the High-Resolution Research Tomograph PET ScannerNonlinear spatio-temporal filtering of dynamic PET data using a four-dimensional Gaussian filter and expectation-maximization deconvolutionThe use of alternative forms of graphical analysis to balance bias and precision in PET images.Risk-taking behavior: dopamine D2/D3 receptors, feedback, and frontolimbic activity.Diminished neurokinin-1 receptor availability in patients with two forms of chronic visceral painReference tissue modeling with parameter coupling: application to a study of SERT binding in HIVDorsal striatal D2-like receptor availability covaries with sensitivity to positive reinforcement during discrimination learning.Effects of Silexan on the serotonin-1A receptor and microstructure of the human brain: a randomized, placebo-controlled, double-blind, cross-over study with molecular and structural neuroimaging.Striatal D1- and D2-type dopamine receptors are linked to motor response inhibition in human subjectsReference region modeling approaches for amphetamine challenge studies with [11C]FLB 457 and PETGray-matter volume, midbrain dopamine D2/D3 receptors and drug craving in methamphetamine users.The dopamine stabilizer (-)-OSU6162 occupies a subpopulation of striatal dopamine D2/D3 receptors: an [(11)C]raclopride PET study in healthy human subjectsIn Vivo Evaluation of Blood Based and Reference Tissue Based PET Quantifications of [11C]DASB in the Canine Brain.A preliminary study of dopamine D2/3 receptor availability and social status in healthy and cocaine dependent humans imaged with [(11)C](+)PHNOLow Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence.Widespread abnormality of the γ-aminobutyric acid-ergic system in Tourette syndrome.Use of spectral analysis with iterative filter for voxelwise determination of regional rates of cerebral protein synthesis with L-[1-11C]leucine PETUsing a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's diseasePlacebo analgesia: Self-report measures and preliminary evidence of cortical dopamine release associated with placebo response.Striatal dopamine D₂/D₃ receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humans
P2860
Q24580478-801FF3DB-5AF3-4074-A58D-092DCE843883Q28540226-CAAE3E35-E5AF-47FC-8E76-4EDB79482FD7Q28551943-0741DC23-E3D1-4C85-8ECD-49F0CD0DB831Q30422060-9B078616-8CDD-44BF-99EA-9331C2417812Q33533741-2AED41C0-79FC-4668-BC7B-6767894D6E0BQ33637117-0AD3B8E0-5993-4512-9DFF-7F6E8DA4F9A8Q33638350-C191760F-77C8-420D-AC2E-307F21640D07Q33654396-7100ACAE-FA3F-4083-B1CD-B86A078A07EDQ33656355-65E20802-1090-456A-99D0-17F33A190B06Q33714533-518D5A41-104F-4ED1-82CF-FEC058B45306Q33809050-9E4D746E-16BC-4156-9CF7-9E95EFD7C987Q33851479-82946339-33DF-485D-BD10-3443F4E4C07AQ33960519-EB2E706B-466E-4957-896C-D9DE4430008DQ33964638-83C93743-3B79-4CF1-8C83-39BD39A3E6F4Q34009095-F265CC4A-8BF1-48D4-A78C-383E6EDACB65Q34030711-C65F9922-F758-4782-A21E-77D7E96DD5D4Q34041532-72A7CA55-09E8-4B3A-BF9C-695285ED0E25Q34170757-B63FA7E4-9313-4578-85DB-63C671E41B8CQ34227983-4EA18CF0-35FB-477B-AAF0-9DB0B89DB16AQ34324345-170561E2-E431-43E3-A720-3D9738A3EC1BQ34362666-4AD934E0-EB4A-46DD-8BA8-FDBD17E9C02DQ34570425-EE2BB1DD-BADA-452F-8A86-400D350AB737Q34627591-7E3C7114-561C-45A7-991E-215E1D327499Q34653399-EE843EF1-9B25-4050-AB20-026EC8C01C64Q34954885-D6B9300F-E111-462A-BFCD-D5572789BE84Q34979527-34CD3A31-F02F-4D31-A639-13EA8863F980Q35044956-0E287099-EC0A-4E1D-AA1A-F1C87C917CF6Q35178976-17AAA2DA-3DB2-4C75-90AB-4C23304F5A3DQ35423597-9CC85251-92B5-4541-B92D-BC1E00C72736Q35572863-EE98626A-45B3-4EFA-9F56-3BE94321539AQ35634676-56B427DE-C12E-49A5-9815-DE37450E59B7Q35647369-F5701504-57B0-467F-9FEB-0EB0EEEBE9B5Q35918437-3D8403FE-E580-40F5-BD4E-7A4B773721BCQ35952369-D53B3AF5-CF99-4782-9823-BA462F4DD996Q35965848-449499EA-5A70-49A5-B409-C0A436DD355CQ35986696-A57B25E3-5C68-48C6-982C-9EB17C8DA67CQ36008253-78000AAD-50A9-42E8-95F8-EDD7925FB1D6Q36026695-CEBC3750-2D5B-495A-AE20-FE4E0F35DB65Q36382450-82213F39-7D31-4F9D-9BD8-6F9F70721D75Q36453185-E9BE76AE-354D-47C3-A42A-354438AD029D
P2860
Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Noise reduction in the simplif ...... roreceptor functional imaging.
@en
Noise reduction in the simplif ...... roreceptor functional imaging.
@nl
type
label
Noise reduction in the simplif ...... roreceptor functional imaging.
@en
Noise reduction in the simplif ...... roreceptor functional imaging.
@nl
prefLabel
Noise reduction in the simplif ...... roreceptor functional imaging.
@en
Noise reduction in the simplif ...... roreceptor functional imaging.
@nl
P2860
P1476
Noise reduction in the simplif ...... roreceptor functional imaging.
@en
P2093
Richard E Carson
P2860
P304
P356
10.1097/00004647-200212000-00004
P577
2002-12-01T00:00:00Z